Bioequivalence Study For Orally-Disintegrating Tablet Of Sildenafil
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the bioequivalence of Sildenafil ODT 50 mg without
water to Japanese commercial oral tablet of sildenafil citrate (Viagra® tablet) 50 mg under
fasted conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.